Jane Endicott
From Wikipedia, the free encyclopedia
Jane Endicott | |
|---|---|
| Alma mater | Corpus Christi College, University of Oxford |
| Awards | MRC Suffrage Science Award |
| Scientific career | |
| Fields | Structural biology, cancer |
| Institutions | Newcastle University, Ontorio Cancer Institute, University of Oxford |
| Academic advisors | Professor Paul Nurse, Professor Louise Johnson, Victor Ling |
Professor Jane Endicott has been a Professor of Cancer Structural Biology at Newcastle University's Faculty of Medical Sciences and a member of the Cancer Research UK Newcastle Drug Discovery Unit since October 2011.[1] She is also a member of the Newcastle University Cancer Leads Group and the Newcastle University Centre for Cancer Fellowships Steering Group, as well as a Emeritus Fellow at St Cross College, University of Oxford.[2]
After studying Biochemistry at Corpus Christi College, the University of Oxford, Endicott completed her PhD at the Ontario Cancer Institute, as part of the laboratory team of Victor Ling. In 1991, she joined the laboratories of Paul Nurse and Louise Johnson at the University of Oxford, as a Junior Research Fellow of the National Cancer Institute of Canada, to conduct research into cyclin-dependent protein kinases (CDKs).
She was awarded a Royal Society University Research Fellowship in 1995, and has a Lectureship at Trinity College, University of Oxford.[3]
Research
Endicott's specialises in cell cycle structural biology and transcription. Her group studies how proteins involved in transcription and other cell cycle processes interact with each other, and whether blocking some of these connections could treat cancer. The lab also works with the Cancer Research UK Newcastle Drug Discovery Unit projects.[1]
Awards
Endicott was awarded a Medical Research Council (MRC) Suffrage Science Award in 2014 for her scientific achievements.[4][5][6]
